Amarantus
BioScience discovers and develops novel diagnostics and therapeutic treatments for neurodegeneration and apoptosis diseases... Read moreAmarantus
BioScience discovers and develops novel diagnostics and therapeutic treatments for neurodegeneration and apoptosis diseases... Read more
News
Apr 27, 2022
StreetInsider
Press Release: Amarantus : Amarantus Signs Non-Binding Term Sheet to Divest Cutanogen Corporation in Exchange for the Extinguishment of Potential $21M+ in Liabilities
Nov 18, 2021
MarketScreener
Amarantus: Amarantus BioScience : Notification of Late Filing
Jul 27, 2020
BioSpace
Amarantus: Todos Medical Completes Acquisition of Breakthrough Diagnostics, Gains Full Rights to the Alzheimer's Blood Diagnostic LymPro Test from Amarantus
Feb 06, 2020
firstwordpharma
Amarantus: Amarantus Announces Subsidiary MANF Therapeutics Enters Into Material Transfer Agreement with Dyadic International
Feb 04, 2020
MarketScreener
Amarantus: Amarantus Releases Letter to Shareholders
Jan 30, 2020
MarketScreener
Amarantus BioScience: Amarantus Acquires Majority Interest in CBD Wellness Company Hempori
Jan 09, 2020
BioSpace
Amarantus BioScience: Todos Medical Enters into Exclusive Option Agreement to Acquire Provista Diagnostics and Announces Management ChangesTodos preparing to relocate headquarters to USA
Jan 02, 2020
NewMediaWire
Press Release: Amarantus BioScience : Amarantus Completes Sublicense of ESS, MANF and PhenoGuard to Emerald Organic Products
Dec 09, 2019
centralcharts
Press Release: Amarantus BioScience : Amarantus to Present at 12th Annual LD Micro Main Event
Dec 04, 2019
MarketScreener
Amarantus BioScience: Amarantus Subsidiary Elto Pharma Receives Notice of Allowance Covering Use of Eltoprazine Combined with CBD to Treat Parkinson's Disease
Amarantus Competitors
1
2
3
4
5
6
7
8
9
10